Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| LANNETT CO INC | 587,145 | reported | 10 Nov 2022 | tx 16+585,445 |
| Matinas BioPharma Holdings, Inc. | 122,605 | reported | 02 Nov 2020 | tx 8+908,320 |
| PAR PHARMACEUTICAL COMPANIES, INC. | 65,000 | reported | 28 Sept 2012 | tx 77+934,862−892,145 |
| Innoviva, Inc. | 58,278 | reported | 20 Apr 2017 | tx 2+58,278 |
| VYNE Therapeutics Inc. |
Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 12 buys in history.
| 20,000 |
| reported |
| 12 Dec 2025 |
| tx 15+314,000 |
| PharMerica CORP | 0 | reported | 07 Dec 2017 | tx 8+35,255−29,570 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 12 Dec 2025 | GRANT_AWARD | VYNE Therapeutics Inc. | 20,000 | 0.00 USD | deriv |
| 15 Jan 2025 | PURCHASE | VYNE Therapeutics Inc. | 15,000 | 2.92 USD | first after silence |
| 12 Dec 2024 | GRANT_AWARD | VYNE Therapeutics Inc. | 20,000 | 0.00 USD | deriv |
| 01 Jan 2024 | GRANT_AWARD | VYNE Therapeutics Inc. | 20,000 | 0.00 USD | deriv |
| 13 Dec 2023 | GRANT_AWARD | VYNE Therapeutics Inc. | 20,000 | 0.00 USD | deriv |
| 15 Nov 2023 | PURCHASE | VYNE Therapeutics Inc. | 13,000 | 3.91 USD | |
| 20 Mar 2023 | PURCHASE | VYNE Therapeutics Inc. | 20,000 | 2.48 USD | |
| 10 Nov 2022 | PURCHASE | LANNETT CO INC | 100,000 | 0.49 USD | |
| 10 Aug 2022 | GRANT_AWARD | VYNE Therapeutics Inc. | 20,500 | 0.00 USD | deriv |
| 16 May 2022 | PURCHASE | LANNETT CO INC | 50,000 | 0.54 USD | |
| 08 Feb 2022 | PURCHASE | LANNETT CO INC | 50,000 | 0.88 USD | |
| 30 Nov 2021 | PURCHASE | VYNE Therapeutics Inc. | 12,500 | 1.02 USD | |
| 29 Nov 2021 | PURCHASE | LANNETT CO INC | 50,000 | 1.71 USD | |
| 08 Sept 2021 | PURCHASE | LANNETT CO INC | 20,000 | 3.31 USD | |
| 31 Aug 2021 | GRANT_AWARD | LANNETT CO INC | 56,819 | 0.00 USD | |
| 25 Aug 2021 | PURCHASE | VYNE Therapeutics Inc. | 12,500 | 1.60 USD | |
| 19 Jul 2021 | GRANT_AWARD | VYNE Therapeutics Inc. | 20,500 | 0.00 USD | deriv |
| 26 May 2021 | PURCHASE | VYNE Therapeutics Inc. | 12,500 | 3.60 USD | |
| 11 May 2021 | PURCHASE | LANNETT CO INC | 20,000 | 4.18 USD | |
| 15 Mar 2021 | PURCHASE | VYNE Therapeutics Inc. | 12,500 | 7.41 USD | |
| 03 Dec 2020 | PURCHASE | VYNE Therapeutics Inc. | 50,000 | 1.71 USD | |
| 02 Nov 2020 | GRANT_AWARD | Matinas BioPharma Holdings, Inc. | 122,605 | 0.00 USD | deriv |
| 10 Sept 2020 | GRANT_AWARD | VYNE Therapeutics Inc. | 45,000 | 0.00 USD | deriv |
| 01 Sept 2020 | GRANT_AWARD | LANNETT CO INC | 38,986 | 0.00 USD | |
| 14 May 2020 | PURCHASE | Matinas BioPharma Holdings, Inc. | 100,000 | 0.73 USD |
4 purchases reported after at least 12 months of silence — most recent on 15 Jan 2025.